How has been the historical performance of HCP Plastene?

Answer:The historical performance of HCP Plastene shows significant fluctuations in key financial metrics over the years.

Breakdown:
HCP Plastene's net sales have varied dramatically, peaking at 11,219.74 Cr in March 2022 before declining to 463.48 Cr in March 2025. The total operating income followed a similar trend, reaching its highest at 11,219.74 Cr in March 2022 and dropping to 463.48 Cr by March 2025. Raw material costs also surged, from 13.67 Cr in March 2021 to 350.34 Cr in March 2025. Operating profit, which was negative in March 2021, improved to 39.87 Cr by March 2025, indicating a recovery despite the decline in sales. Profit before tax turned positive at 17.96 Cr in March 2025, up from a loss of 315.92 Cr in March 2022. The profit after tax showed a similar recovery, reaching 13.31 Cr in March 2025 after being negative in previous years. The consolidated net profit also turned positive at 9.63 Cr in March 2025, compared to losses in the preceding years. On the balance sheet, total liabilities increased from 48.70 Cr in March 2021 to 206.70 Cr in March 2024, while total assets rose from 48.70 Cr to 206.70 Cr in the same period. Cash flow from operating activities remained negative, indicating ongoing challenges in generating cash from core operations. Overall, HCP Plastene has shown signs of recovery in profitability metrics despite significant fluctuations in sales and costs.